Nutritional Supplementation in Children Aged 1-3 Years Experiencing Growth Concerns

NCT ID: NCT04766346

Last Updated: 2022-11-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

168 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-02-26

Study Completion Date

2022-10-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This open-label clinical trial will gain evidence of the effect of an oral Nutritional Supplement (NS) to help improve catch-up growth and support learning skills in children with growth concerns.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Growth Learning Toddlers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Nutritional Supplement

The NS is a fortified cow's milk-based product provided in powdered form.

Group Type EXPERIMENTAL

Fortified Cow's Milk-Based Oral Nutritional Supplement

Intervention Type OTHER

The NS is a fortified cow's milk-based product provided in powdered form that provides the appropriate amount of energy and protein to promote growth in children.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fortified Cow's Milk-Based Oral Nutritional Supplement

The NS is a fortified cow's milk-based product provided in powdered form that provides the appropriate amount of energy and protein to promote growth in children.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Evidence of a personally signed and dated informed consent document indicating that the child's parent(s) / legally acceptable representative (LAR) has been informed of all pertinent aspects of the study.
2. Child was full-term at birth (i.e., ≥ 37 completed weeks of gestation with a birth weight of ≥ 2.5 kg and ≤ 4.5 kg).
3. Child is age 12 - 36 months and generally healthy (acute illness in a minor condition which are common in childhood such as viral or bacterial infection e.g. conjunctivitis, otitis media, upper/lower respiratory tract infection, gastroenteritis, hand foot \& mouth disease at time of enrolment is permitted).
4. Children whose parents show some concern about their child's growth, such as child is too thin for his or her length/height, child has experienced recent rapid weight loss or failure to gain weight or length/height, or child's growth curve shows a downward trajectory of growth velocity
5. Child has a weight-for-length/height ≤ 25th percentile as per WHO growth charts.
6. Parents agree to feed their child a nutritional supplement in addition to normal diet.
7. Child's parent(s) / guardian can be contacted directly by telephone or email throughout the study.
8. Child's parent is of legal age of consent, must understand the informed consent form and other study documents, and is willing and able to fulfill the requirements of the study protocol.

Exclusion Criteria

1. Child is currently breastfed or is consuming breast milk
2. Child has known or suspected cows' milk protein intolerance / allergy, lactose intolerance, soy intolerance / allergy, fish oil intolerance / allergy, or other food allergies that impact diet.
3. Child fed vegan, vegetarian, or vegetarian plus fish diets in which milk products are excluded
4. Child has chronic illness or other disease including any condition that impacts feeding or growth
5. Child having any congenital malformation (e.g., gastrointestinal tract atresia) or surgery sequelae (e.g., short bowel syndrome) potentially affecting feeding or growth
6. Child has been diagnosed with Infantile anorexia nervosa
7. Child has other medical or psychiatric condition that, in the judgement of the investigator, would make the child inappropriate for entry into the study.
8. Child or child's parent(s) not willing and/or not able to comply with scheduled visits and the requirements of the study protocol.
9. Child of any investigational site staff member or Nestlé employee directly involved in the conduct of the trial.
10. Child is currently participating in or has participated in another clinical trial within 4 weeks prior to enrolment.
Minimum Eligible Age

1 Year

Maximum Eligible Age

3 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Société des Produits Nestlé (SPN)

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Las Piñas Doctors Hospital

Las Piñas, , Philippines

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Philippines

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20.09.INF

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Efficacy of a Dietary Supplement in Infants
NCT07341477 NOT_YET_RECRUITING NA
Probiotic Formula and Infant Growth
NCT01476397 COMPLETED NA
Prebiotic in Preterm Infants
NCT03306316 COMPLETED NA
Starter Infant Formula With Synbiotics
NCT06073652 ACTIVE_NOT_RECRUITING NA
Safety and Efficacy Study
NCT02670863 COMPLETED NA
Toddler Milk Intervention Trial
NCT02907502 COMPLETED NA